Press Room

WASHINGTON, D.C. – Yesterday, the U.S.

Today, legislation aiming to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans, was voted out of committee and will soon be heard by the full House. This marks the final step before the bill goes to Governor Matt Meyer who, earlier this year, identified biomarker testing access as a priority.

HELENA, Mont. -- Cigarette use continues to take a heavy toll in Montana, claiming about 1,600 lives each year. Against this backdrop, a new statewide poll finds broad support across political parties for proven policies that can prevent tobacco use and save lives.

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the Department of Health and Hu

DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.

SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.

Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).

In late May, the Office of Management and Budget (OMB) released a 

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see the Louisiana Medical Debt Protections Act (SB 414) signed into law.

COLUMBIA, S.C. – “Nearly 40,000 South Carolinians will be diagnosed with cancer this year. Tobacco is the leading cause of preventable death in the United States.